
What is the clinical evidence for mitral TEER?
Learn about outcomes from a large randomised trial, and early feasibility and post-market studies.
Help your patients learn about mitral regurgitation (MR) and the potential treatment options and outcomes. Your patients could start a new chapter of life with transcatheter edge-to-edge repair (TEER).
From diagnosis to recovery, each tale depicts the individual's journey through MR and emphasises the significant influence of TEER on their lives.
Gain the latest insights from Edwards Lifesciences to stay informed about MR and TEER.
Sign up for the newsletter for valuable resources, including:
For a listing of indications, contraindications, precautions, warnings and potential adverse events, please refer to the Instructions for Use (consult eifu.edwards.com where applicable).
PP--EU-10019 v1.0
Edwards Lifesciences Sàrl • Route de l’Etraz 70, 1260 Nyon, Switzerland • edwards.com